The FIVB, World Anti-Doping Agency (WADA) and volleyball player Anna Vozakova have signed a case resolution agreement according to which Ms Vozakova admitted that the prohibited substance of Sibutramine was found in her sample collected in-competition on 24 June 2012 during the CEV Continental Cup final in Moscow, Russia.

The case is part of investigations that the FIVB started after WADA provided data and information related to test samples collected from the Moscow Laboratory.

According to the case resolution agreement, the player admitted that she committed an anti-doping rule violation under Article 2.2 of the FIVB Medical Regulations 2011. As a result, she has been sanctioned with a period of ineligibility of twenty-four (24) months starting on 11 January 2022 and ending on 11 January 2024.

The case resolution agreement is not subject to appeal under Article 13 of the FIVB Medical and Anti-Doping Regulations 2022.

The FIVB is committed to protecting fair play and clean athletes, and maintains a zero-tolerance approach to doping.